227 related articles for article (PubMed ID: 22301215)
21. New tuberculosis drugs on the horizon.
Cole ST; Riccardi G
Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
[TBL] [Abstract][Full Text] [Related]
23. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and anti-mycobacterial activity of novel amino alcohol derivatives.
Cunico W; Gomes CR; Ferreira ML; Ferreira TG; Cardinot D; de Souza MV; Lourenço MC
Eur J Med Chem; 2011 Mar; 46(3):974-8. PubMed ID: 21295888
[TBL] [Abstract][Full Text] [Related]
25. Ring-substituted quinolines as potential anti-tuberculosis agents.
Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
[TBL] [Abstract][Full Text] [Related]
26. Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Onajole OK; Govender K; Govender P; van Helden PD; Kruger HG; Maguire GE; Muthusamy K; Pillay M; Wiid I; Govender T
Eur J Med Chem; 2009 Nov; 44(11):4297-305. PubMed ID: 19679378
[TBL] [Abstract][Full Text] [Related]
27. Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv.
Shindikar AV; Viswanathan CL
Bioorg Med Chem Lett; 2005 Apr; 15(7):1803-6. PubMed ID: 15780610
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of (S,S)-N,N'-bis-[3-(2,2',6,6'-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity.
Zhang X; Hu Y; Chen S; Luo R; Yue J; Zhang Y; Duan W; Wang H
Bioorg Med Chem Lett; 2009 Nov; 19(21):6074-7. PubMed ID: 19796945
[TBL] [Abstract][Full Text] [Related]
29. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore.
Salunke SB; Azad AK; Kapuriya NP; Balada-Llasat JM; Pancholi P; Schlesinger LS; Chen CS
Bioorg Med Chem; 2015 May; 23(9):1935-43. PubMed ID: 25818768
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.
Lu X; Wan B; Franzblau SG; You Q
Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695
[TBL] [Abstract][Full Text] [Related]
32. An efficient synthesis of aryloxyphenyl cyclopropyl methanones: a new class of anti-mycobacterial agents.
Dwivedi N; Tewari N; Tiwari VK; Chaturvedi V; Manju YK; Srivastava A; Giakwad A; Sinha S; Tripathi RP
Bioorg Med Chem Lett; 2005 Oct; 15(20):4526-30. PubMed ID: 16087335
[TBL] [Abstract][Full Text] [Related]
33. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA
J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis.
Upadhayaya RS; Vandavasi JK; Vasireddy NR; Sharma V; Dixit SS; Chattopadhyaya J
Bioorg Med Chem; 2009 Apr; 17(7):2830-41. PubMed ID: 19285414
[TBL] [Abstract][Full Text] [Related]
35. Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners.
Kamal A; Shetti RV; Azeeza S; Ahmed SK; Swapna P; Reddy AM; Khan IA; Sharma S; Abdullah ST
Eur J Med Chem; 2010 Oct; 45(10):4545-53. PubMed ID: 20705368
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
Bacelar AH; Carvalho MA; Proença MF
Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
[TBL] [Abstract][Full Text] [Related]
37. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
[TBL] [Abstract][Full Text] [Related]
38. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
40. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
